Catalyst

Slingshot members are tracking this event:

Phase 2b preliminary topline data of Selinexor - SADAL trial for Diffuse Large B-Cell Lymphoma due Q4 2016

Source Link:
http://investors.karyopharm.com/releasedetail.cfm?ReleaseID=941474

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
KPTI
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Preliminary top-line data from the SOPRA and SADAL studies are anticipated in the fourth quarter of 2016.
http://investors.kar...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 06, 2016
Occurred Source:
http://investors.karyopharm.com/releasedetail.cfm?ReleaseID=987776
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2b Preliminary Topline Data, Selinexor, Sadal Trial, Diffuse Large B-cell Lymphoma, Dlbcl, Q4 2016
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.